Published in PLoS One on November 17, 2016
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81
Osteoclast differentiation and activation. Nature (2003) 18.59
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell (1997) 15.96
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl (2009) 12.66
osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev (1998) 7.81
Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin. Circ Res (2004) 2.63
Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice. Circulation (2008) 2.44
Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology (1999) 2.27
Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. J Exp Med (2000) 2.20
Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women. J Clin Endocrinol Metab (2001) 2.14
Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease. Circulation (2004) 2.08
Association of kidney function with incident hip fracture in older adults. J Am Soc Nephrol (2006) 1.92
The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. Bone (2003) 1.51
Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure. Circulation (2005) 1.38
Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: the Rancho Bernardo study. J Bone Miner Res (2007) 1.31
Correlates of osteoprotegerin levels in women and men. Osteoporos Int (2002) 1.31
Serum levels of osteoprotegerin increase with age in a healthy adult population. Bone (2003) 1.23
Estimating prevalence of osteoporosis: examples from industrialized countries. Arch Osteoporos (2014) 1.23
17beta-estradiol stimulates expression of osteoprotegerin by a mouse stromal cell line, ST-2, via estrogen receptor-alpha. Endocrinology (2001) 1.19
Bone mineral density and fracture risk in older individuals with CKD. Clin J Am Soc Nephrol (2012) 1.18
Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status. J Clin Endocrinol Metab (2001) 1.16
The sex-specific association of serum osteoprotegerin and receptor activator of nuclear factor kappaB legend with bone mineral density in older adults: the Rancho Bernardo study. Eur J Endocrinol (2007) 1.15
Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction. Clin Sci (Lond) (2005) 1.12
Osteoprotegerin, RANKL and bone turnover in postmenopausal osteoporosis. J Clin Pathol (2011) 1.07
Osteoporosis and sarcopenia in older age. Bone (2015) 1.05
KNOW-CKD (KoreaN cohort study for Outcome in patients With Chronic Kidney Disease): design and methods. BMC Nephrol (2014) 1.04
Low bone mineral density and fractures in stages 3-5 CKD: an updated systematic review and meta-analysis. Osteoporos Int (2014) 1.03
Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo. Blood (2007) 1.03
Serum osteoprotegerin as a screening tool for coronary artery calcification score in diabetic pre-dialysis patients. Hypertens Res (2008) 1.01
Circulating osteoprotegerin and receptor activator of NF-kappaB ligand system are associated with bone metabolism in middle-aged males. Clin Endocrinol (Oxf) (2005) 1.00
The proportion of trabecular bone in human vertebrae. J Bone Miner Res (1987) 1.00
Regulation of osteoprotegerin production by androgens and anti-androgens in human osteoblastic lineage cells. Eur J Endocrinol (2002) 0.98
Bone mineral density predicts fractures in chronic kidney disease. J Bone Miner Res (2015) 0.98
Testosterone increases osteoprotegerin mRNA expression in mouse osteoblast cells. Horm Metab Res (2004) 0.96
Signaling Pathways in Osteoclast Differentiation. Chonnam Med J (2016) 0.94
Serum osteoprotegerin measurement for early diagnosis of chronic kidney disease-mineral and bone disorder. Nephrology (Carlton) (2011) 0.89
OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice. Proc Natl Acad Sci U S A (2014) 0.89
Circulating profiles of osteoprotegerin and soluble receptor activator of nuclear factor kappaB ligand in post-menopausal women. J Endocrinol Invest (2008) 0.88
Studies of bone morphology, bone densitometry and laboratory data in patients on maintenance hemodialysis treatment. Nephron (1985) 0.87
Age at First Delivery and Osteoporosis Risk in Korean Postmenopausal Women: The 2008-2011 Korea National Health and Nutrition Examination Survey (KNHANES). PLoS One (2015) 0.86
Serum osteoprotegerin is a major determinant of bone density development and prevalent vertebral fracture status following cardiac transplantation. Bone (2003) 0.86
Osteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status. Wien Klin Wochenschr (2003) 0.86
The effect of RANKL and OPG on bone mineral density in pre-dialysis chronic renal failure. Clin Nephrol (2009) 0.80
Women and CKD-mineral and bone disorder. Adv Chronic Kidney Dis (2013) 0.79
GFR and cardiovascular outcomes after acute myocardial infarction: results from the Korea Acute Myocardial Infarction Registry. Am J Kidney Dis (2012) 1.12
Pleural effusion in a peritoneal dialysis patient. Chonnam Med J (2011) 0.98
Vitamin D and chronic kidney disease. Korean J Intern Med (2014) 0.91
Association of pulse wave velocity and pulse pressure with decline in kidney function. J Clin Hypertens (Greenwich) (2014) 0.91
Incidence, predictive factors, and clinical outcomes of acute kidney injury after gastric surgery for gastric cancer. PLoS One (2013) 0.91
Gross hematuria associated with genitourinary tuberculosis. Chonnam Med J (2013) 0.90
Rosiglitazone prevents the progression of renal injury in DOCA-salt hypertensive rats. Hypertens Res (2010) 0.87
4-Hydroxy-2-hexenal-induced apoptosis in human renal proximal tubular epithelial cells. Nephrol Dial Transplant (2011) 0.87
SIADH associated with prostate cancer. Electrolyte Blood Press (2007) 0.86
Metabolic syndrome and chronic kidney disease in an adult Korean population: results from the Korean National Health Screening. PLoS One (2014) 0.86
Socioeconomic disparities in osteoporosis prevalence: different results in the overall Korean adult population and single-person households. J Prev Med Public Health (2015) 0.84
Concomitant renal insufficiency and diabetes mellitus as prognostic factors for acute myocardial infarction. Cardiovasc Diabetol (2011) 0.84
Relation of serum potassium level to long-term outcomes in patients with acute myocardial infarction. Am J Cardiol (2014) 0.84
Activation of the Renal PI3K/Akt/mTOR Signaling Pathway in a DOCA-Salt Model of Hypertension. Chonnam Med J (2012) 0.83
Farnesoid X receptor ligand prevents cisplatin-induced kidney injury by enhancing small heterodimer partner. PLoS One (2014) 0.82
Renoprotective effects of the direct renin inhibitor aliskiren on gentamicin-induced nephrotoxicity in rats. J Renin Angiotensin Aldosterone Syst (2013) 0.81
Renoprotective effects of sildenafil in DOCA-salt hypertensive rats. Kidney Blood Press Res (2012) 0.81
alpha-Lipoic acid prevents cisplatin-induced acute kidney injury in rats. Nephrol Dial Transplant (2009) 0.80
Angiotensin-(1-7) Attenuates Kidney Injury Due to Obstructive Nephropathy in Rats. PLoS One (2015) 0.79
Altered Nitric Oxide System in Cardiovascular and Renal Diseases. Chonnam Med J (2016) 0.79
Hyponatremia associated with bupropion. Electrolyte Blood Press (2011) 0.79
Pathogenesis of oedema in nephrotic syndrome: role of epithelial sodium channel. Nephrology (Carlton) (2007) 0.79
Pharmacologic Management of the Cardio-renal Syndrome. Electrolyte Blood Press (2013) 0.79
Effects of antioxidant drugs in rats with acute renal injury. Electrolyte Blood Press (2007) 0.79
Baseline Cardiovascular Characteristics of Adult Patients with Chronic Kidney Disease from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD). J Korean Med Sci (2017) 0.78
Increased Phosphorylation of PI3K/Akt/mTOR in the Obstructed Kidney of Rats with Unilateral Ureteral Obstruction. Chonnam Med J (2013) 0.78
Association of metabolic syndrome and renal insufficiency with clinical outcome in acute myocardial infarction. Metabolism (2012) 0.78
Effects of rosiglitazone on heat shock protein and the endothelin system in deoxycorticosterone acetate-salt hypertensive rats. Electrolyte Blood Press (2008) 0.78
Altered renal expression of aquaporin water channels and sodium transporters in rats with two-kidney, one-clip hypertension. Kidney Blood Press Res (2009) 0.77
Neutrophil gelatinase-associated lipocalin as a predictor of adverse renal outcomes in immunoglobulin A nephropathy. Korean J Intern Med (2015) 0.77
Altered regulation of nitric oxide and natriuretic peptide system in cisplatin-induced nephropathy. Regul Pept (2011) 0.77
Altered regulation of renin-angiotensin, endothelin and natriuretic peptide systems in rat kidney with chronic unilateral ureteral obstruction. Urol Int (2007) 0.77
Association of serum adiponectin level with albuminuria in chronic kidney disease patients. Clin Exp Nephrol (2015) 0.77
Increased renal expression of aquaporin-3 in rats inhibited type 2 11beta-hydroxysteroid dehydrogenase. Kidney Blood Press Res (2007) 0.77
Water and sodium regulation in heart failure. Electrolyte Blood Press (2009) 0.76
Hypernatemia : successful treatment. Electrolyte Blood Press (2006) 0.76
Nicotine-Induced Apoptosis in Human Renal Proximal Tubular Epithelial Cells. PLoS One (2016) 0.76
Determinants and burden of chronic kidney disease in a high-risk population in Korea: results from a cross-sectional study. Korean J Intern Med (2016) 0.75
Biomarkers Predicting Survival of Sepsis Patients Treated with Continuous Renal Replacement Therapy. Chonnam Med J (2017) 0.75
Extreme Metabolic Alkalosis Caused by Gastrostomy Tube Malposition Treated Using Conventional Hemodialysis. Chonnam Med J (2016) 0.75
Hydronephrosis caused by a giant ovarian cyst. Int Braz J Urol (2016) 0.75
Altered Regulation of type 3 Na(+)/H(+) exchanger, type 1 Na(+)/HCO3 (-) cotransporter, and Na(+),K(+)-ATPase in the Kidney of Rats with Experimental Rhabdomyolysis. Electrolyte Blood Press (2007) 0.75
Severe Ketoacidosis in a Patient with an Eating Disorder. Chonnam Med J (2016) 0.75
Hypercalcemia in a patient with polycythemia vera. Chonnam Med J (2012) 0.75
Altered Regulation of Type II 11β-hydroxysteroid Dehydrogenase in the Kidney of Rats with Experimental Hypertension. Electrolyte Blood Press (2007) 0.75
Risk factors for in-hospital mortality in patients starting hemodialysis. Kidney Res Clin Pract (2015) 0.75
Impact of Transient and Persistent Acute Kidney Injury on Chronic Kidney Disease Progression and Mortality after Gastric Surgery for Gastric Cancer. PLoS One (2016) 0.75
A Case of Acute Pyelonephritis in Bilateral Renal Malrotation. Chonnam Med J (2016) 0.75
Consecutive episodes of peritonitis in a patient undergoing peritoneal dialysis caused by unusual organisms: Brevibacterium and Pantoea agglomerans. Kidney Res Clin Pract (2012) 0.75
Chronic Kidney Disease-Mineral Bone Disorder in Korean Patients: a Report from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD). J Korean Med Sci (2017) 0.75
A case of Creutzfeldt-Jakob disease in a patient on hemodialysis. Kidney Res Clin Pract (2012) 0.75